Journals / Retina-Vitreus / 2005 / Cilt: 13 - Sayı: 4

The evaluation of macular changes after intravitreal triamcinolone acetonide in branch retinal vein occlusion

Retina ven dal tıkanıklığında intravitreal triamsinolon asetonid tedavisi sonrası maküladaki değişikliklerin incelenmesi

Pages
273–277
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: The results of our study showed resolution of CME and serous macular detachment with corresponding improved visual acuity in patients with branch retinal vein occlusion after intravitreal triamcinolone acetonide injection.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate the effect of intravitreal triamcinolone acetonide on the macular morphology in patients with cystoid macular edema (CME) secondary to branch retinal vein occlusion.
📊
Key Findings & Data:Materials and Methods: Ten eyes of 10 patients with CME secondary to the branch retinal vein occlusion aged 46 to 75 years (average 62.8) made up the study population.
💡
Conclusion & Impact:Conclusions: The results of our study showed resolution of CME and serous macular detachment with corresponding improved visual acuity in patients with branch retinal vein occlusion after intravitreal triamcinolone acetonide injection.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Triamsinolon asetonit · Retinal ven tıkanıklığı · Tedavi sonucu

Abstract

Purpose: To evaluate the effect of intravitreal triamcinolone acetonide on the macular morphology in patients with cystoid macular edema (CME) secondary to branch retinal vein occlusion. Materials and Methods: Ten eyes of 10 patients with CME secondary to the branch retinal vein occlusion aged 46 to 75 years (average 62.8) made up the study population. After intravitreal injection of 0.1 mL (4 mg) triamcinolone acetonide the visual and anatomic responses were observed. Post-treatment optical coherence tomography changes were evaluated. Results: Pretreatment optical coherence tomography findings showed the presence of CME in 10 eyes (100%) and the presence of serous macular detachment in 8 eyes (80%). After an injection of triamcinolone acetonide, both CME and serous macular detachment were regressed. At 3 months CME and serous macular detachment had recurred in 4 (40%) and CME recurred in 1 eyes (10%). At 6 months CME and serous macular detachment had recurred in 5 (50%) and CME recurred in 1 eyes (10%). Patients with recurrence were retreated. At 1 month all eyes showed improvement in visual acuity. At 3 months no eyes had lost vision from baseline but recurrent 5 cases (50%) showed decreased visual acuity. At 6 months, again no eyes had lost vision from baseline but recurrent 6 cases (60%) showed decreased visual acuity. Conclusions: The results of our study showed resolution of CME and serous macular detachment with corresponding improved visual acuity in patients with branch retinal vein occlusion after intravitreal triamcinolone acetonide injection.

Özet

Amaç: Retina ven dal tıkanıklığı nedeniyle kistoid maküla ödemi (KMÖ) bulunan olgularda intravitreal triamsinolon asetonidin maküla morfolojisi üzerindeki etkilerini incelemek. Gereç ve Yöntem: Retina ven dal tıkanıklığı sonucu KMÖ gelişen yaşları 46 ile 75 arasında olan (ortalama yaş 62.8) 10 olgunun, 10 gözü çalışma grubunu oluşturdu. 0.1 ml (4mg) intravitreal triamsinolon asetonid injeksiyonu sonrası görsel ve anatomik sonuçlar incelendi. Tedavi uygulaması sonrası optik koherens tomografi değişiklikleri tespit edildi. Sonuç: Tedavi öncesi optik koherens tomografi bulguları 10 olguda (%100) KMÖ, 8 olguda (%80) seröz maküla dekolmanı varlığını gösterdi. İntravitreal triamsinolon asetonid injeksiyonu sonrası KMÖ ve seröz maküla dekolmanları geriledi. Üçüncü ayda 4 olguda (%40) KMÖ ve seröz maküla dekolmanı, bir olguda (%10) KMÖ nüks etti. Altıncı ayda ise 5 olguda (%50) KMÖ ve seröz maküla dekolmanı, bir olguda (%10) KMÖ nüks etti. Nüks gözlenen olgularda yeniden tedavi uygulaması yapıldı. Tedavi sonrası birinci ayda tüm olgularda görme keskinliği arttı. Üçüncü ayda hiçbir olguda görme keskinlikleri başlangıç değerlerinin altına inmezken, nüks gözlenen 5 olguda (%50) görme keskinliğinde azalma izlendi. Altıncı ayda da hiçbir olguda görme keskinlikleri başlangıç değerlerinin altına inmezken, nüks gözlenen 6 olguda (%60) görme keskinliğinde azalma oldu. Tartışma: Çalışmamızın sonuçları retina ven dal tıkanıklığı nedeniyle intravitreal triamsinolon asetonid injeksiyonu yapılan olgularda KMÖ’nin ve seröz maküla dekolmanının gerilediğini ve görme keskinliğinin arttığını göstermiştir.

🔖

Cite This Article

KARAÇORLU, S. A., KARAÇORLU, M., ÖZDEMİR, H. (2005). The evaluation of macular changes after intravitreal triamcinolone acetonide in branch retinal vein occlusion. Retina-Vitreus, Cilt: 13 - Sayı: 4, 273–277. https://ajindex.com/articles/305300

References (1)

  1. Shilling JS, Jones CA: Retinal branch vein occlusion: a study of argon laser photocoagulation in the treatment of macular edema. Br J Ophthalmol 1984;68:196-198 2. Gutman FA, Zegarra H: Macular edema secondary to occlusion of the retinal veins. Surv Ophthalmol 1984;28:464-470. 3. The Branch Vein Occlusion Study Group: Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 1984;98:271-82 4. Chen SDM, Lochhead J, Patel CK, et al.: Intravitreal triamcina-lone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion. Br J Ophthalmol 2004; 88: 154-155. 5. Jonas JB, Akkoyun I, Kamppeter B, et al.: Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide. Eye 2004; 23 [Epub ahead of print]. 6. Karaçorlu S: Optical coherence tomography (OCT). Ret-Vit 1999;7:97-103. 7. Spaide RF, Lee JK, Klancnik JM, et al.: Optical coherence tomography of branch retinal vein occlusion. Retina 2003,23:343-347. 8. Özdemir H, Karaçorlu M, Karaçorlu S: Retina ven dal tıkanıklığında seröz maküla dekolmanı. Ret-Vit 2004,12:112-115. 9. Vinores SA, Sen H, Campochiaro PA: An adenosineagonist and prostaglandin El cause breakdown of blood-retinal barrier by opening tight junctions between vascular endothelial cells. Invest Ophthalmol Vis Sei 1992;33:1870-1878. 10. Karaçorlu M, Özdemir H, Karaçorlu S: Intravitreal triamcinolone acetonide for the treatment of chronic pseudophakic cystoid macular edema. Acta Ophthalmol Scand 2003;81:648-652M 11. Karaçorlu M, Özdemir H, Karaçorlu S, et al.: Intravitreal "triamcinolone as a primary therapy in diabetic macular oedema. Eye 2005. 12. Karaçorlu M, Özdemir H, Karaçorlu S: Santral retina ven tıkanıklığına bağlı maküla ödemi tedavisinde intravitreal triamsinolon asetonid. T Oft Gaz 2003;33:742-749. 13. Penfold PL, Wong JG, Gyory J, et al.: Effects of triamcinolone acetonide on microglial morphology and quantitative expression of MHC-II in exudative age-related macular degeneration. Clin Experiment Ophthalmol 2001;29:188-192. 14. Penfold PL, Wen L, Madigan MC, et al.: Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration. Clin Exp Immunol 2000;121:458-465.